CCRM, Canada
Lise Munsie earned her PhD at McMaster University focusing on drug discovery in neurodegenerative diseases. Following this, she completed a post-doctoral research fellowship at the Centre for Applied Neurogenetics at the University of British Columbia where she focused on the genetic causes of Parkinson’s Disease. Lise joined CCRM in 2015 and is currently the Vice President of the Induced Pluripotent Stem Cell (iPSC) Technology Platform. Lise manages iPSC reprogramming, gene editing, cell banking, scale-up and differentiation projects. Lise’s team critical focus is enabling these technologies to be manufactured to produce clinically relevant products.
FRONTIERS IN EPIGENETIC CONTROL FOR ENHANCED STEM CELL THERAPIES
Wednesday, July 10, 2024
4:00 PM – 5:30 PM CEST
MOVING iPSC BASED CGT INTO A GMP SETTING
Thursday, July 11, 2024
3:40 PM – 3:55 PM CEST